Brief: Harpoon Therapeutics Presents Data For New Protritac Development Candidates In TROP2- And ITGB6-Expressing Solid Tumors At AACR
17/04/2023 19:41
April 17 (Reuters) - Harpoon Therapeutics Inc HARP.O :
* HARPOON THERAPEUTICS PRESENTS DATA FOR NEW PROTRITAC™
DEVELOPMENT CANDIDATES IN TROP2- AND ITGB6-EXPRESSING SOLID
TUMORS AT AACR 2023
Source text for Eikon: ID:nGNX6RKv3g
Further company coverage: HARP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harpoon Therapeutics
See all newsBrief: Harpoon Therapeutics Receives 17 Additional Demands Seeking Disclosures in Proxy Statement
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals